Multiple Origins of Virus Persistence during Natural Control of HIV Infection

Cell

Volumn 166, Issue 4, 2016, Pages 1004-1015

  Boritz, Eli A ^a   Darko, Samuel ^a   Swaszek, Luke ^a   Wolf, Gideon ^a   Wells, David ^b   Wu, Xiaolin ^b   Henry, Amy R ^a   Laboune, Farida ^a   Hu, Jianfei ^a   Ambrozak, David ^a   Hughes, Marybeth S ^c   Hoh, Rebecca ^d   Casazza, Joseph P ^a   Vostal, Alexander ^a   Bunis, Daniel ^a   Nganou Makamdop, Krystelle ^a   Lee, James S ^a   Migueles, Stephen A ^a   Koup, Richard A ^a   Connors, Mark ^a   Moir, Susan ^a   Schacker, Timothy ^f   Maldarelli, Frank ^e   Hughes, Stephen H ^e   Deeks, Steven G ^d   Douek, Daniel C ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CELL CLONE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; DNA SEQUENCE; GENE REPLICATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION CONTROL; LYMPH NODE; LYMPHOID TISSUE; MEMORY CELL; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE SUBPOPULATION; VIRAL GENETICS; VIRUS DETECTION; VIRUS REPLICATION; CHRONIC DISEASE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MONONUCLEAR CELL; PHYSIOLOGY; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY;

BLOOD; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; PROVIRUSES; SEQUENCE ANALYSIS, DNA; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUS REPLICATION;

EID: 84981318384     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.06.039     Document Type: Article

References (41)

1. Abdel-Mohsen, M., Raposo, R.A., Deng, X., Li, M., Liegler, T., Sinclair, E., Salama, M.S., Ghanem, Hel.-D., Hoh, R., Wong, J.K., et al. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology, 10, 2013, 106.
2. Archin, N.M., Liberty, A.L., Kashuba, A.D., Choudhary, S.K., Kuruc, J.D., Crooks, A.M., Parker, D.C., Anderson, E.M., Kearney, M.F., Strain, M.C., et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487 (2012), 482–485.
3. ∗57+ elite suppressors despite CTL escape mutations. J. Exp. Med. 203 (2006), 1357–1369.
4. Blankson, J.N., Bailey, J.R., Thayil, S., Yang, H.C., Lassen, K., Lai, J., Gandhi, S.K., Siliciano, J.D., Williams, T.M., Siliciano, R.F., Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J. Virol. 81 (2007), 2508–2518.
5. Boufassa, F., Lechenadec, J., Meyer, L., Costagliola, D., Hunt, P.W., Pereyra, F., Deeks, S., Pancino, G., Taulera, O., Lichterfeld, M., et al. ANRS CO18 HIV Controllers Cohort Cascade Collaboration in Eurocoord SCOPE Cohort, International HIV Controllers Study. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. PLoS ONE, 9, 2014, e85516.
6. Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F.A., Yassine-Diab, B., Boucher, G., Boulassel, M.R., Ghattas, G., Brenchley, J.M., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15 (2009), 893–900.
7. Chun, T.W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J.A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T.C., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387 (1997), 183–188.
8. Chun, T.W., Stuyver, L., Mizell, S.B., Ehler, L.A., Mican, J.A., Baseler, M., Lloyd, A.L., Nowak, M.A., Fauci, A.S., Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94 (1997), 13193–13197.
9. Chun, T.W., Shawn Justement, J., Murray, D., Kim, C.J., Blazkova, J., Hallahan, C.W., Benko, E., Costiniuk, C.T., Kandel, G., Ostrowski, M., et al. Effect of antiretroviral therapy on HIV reservoirs in elite controllers. J. Infect. Dis. 208 (2013), 1443–1447.
10. Cohn, L.B., Silva, I.T., Oliveira, T.Y., Rosales, R.A., Parrish, E.H., Learn, G.H., Hahn, B.H., Czartoski, J.L., McElrath, M.J., Lehmann, C., et al. HIV-1 integration landscape during latent and active infection. Cell 160 (2015), 420–432.
11. Finzi, D., Hermankova, M., Pierson, T., Carruth, L.M., Buck, C., Chaisson, R.E., Quinn, T.C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278 (1997), 1295–1300.
12. Finzi, D., Blankson, J., Siliciano, J.D., Margolick, J.B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5 (1999), 512–517.
13. Fukazawa, Y., Lum, R., Okoye, A.A., Park, H., Matsuda, K., Bae, J.Y., Hagen, S.I., Shoemaker, R., Deleage, C., Lucero, C., et al. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat. Med. 21 (2015), 132–139.
14. + tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124 (2014), 2246–2259.
15. Hatano, H., Yukl, S.A., Ferre, A.L., Graf, E.H., Somsouk, M., Sinclair, E., Abdel-Mohsen, M., Liegler, T., Harvill, K., Hoh, R., et al. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog., 9, 2013, e1003691.
16. Hermankova, M., Siliciano, J.D., Zhou, Y., Monie, D., Chadwick, K., Margolick, J.B., Quinn, T.C., Siliciano, R.F., Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J. Virol. 77 (2003), 7383–7392.
17. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., Markowitz, M., Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995), 123–126.
18. Ho, Y.C., Shan, L., Hosmane, N.N., Wang, J., Laskey, S.B., Rosenbloom, D.I., Lai, J., Blankson, J.N., Siliciano, J.D., Siliciano, R.F., Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155 (2013), 540–551.
19. Hunt, P.W., Brenchley, J., Sinclair, E., McCune, J.M., Roland, M., Page-Shafer, K., Hsue, P., Emu, B., Krone, M., Lampiris, H., et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197 (2008), 126–133.
20. Hunt, P.W., Landay, A.L., Sinclair, E., Martinson, J.A., Hatano, H., Emu, B., Norris, P.J., Busch, M.P., Martin, J.N., Brooks, C., et al. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS ONE, 6, 2011, e15924.
21. Julg, B., Pereyra, F., Buzón, M.J., Piechocka-Trocha, A., Clark, M.J., Baker, B.M., Lian, J., Miura, T., Martinez-Picado, J., Addo, M.M., Walker, B.D., Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers. Clin. Infect. Dis. 51 (2010), 233–238.
22. Kim, M., Siliciano, R.F., Reservoir expansion by T-cell proliferation may be another barrier to curing HIV infection. Proc. Natl. Acad. Sci. USA 113 (2016), 1692–1694.
23. Krishnan, S., Wilson, E.M., Sheikh, V., Rupert, A., Mendoza, D., Yang, J., Lempicki, R., Migueles, S.A., Sereti, I., Evidence for innate immune system activation in HIV type 1-infected elite controllers. J. Infect. Dis. 209 (2014), 931–939.
24. Maldarelli, F., Wu, X., Su, L., Simonetti, F.R., Shao, W., Hill, S., Spindler, J., Ferris, A.L., Mellors, J.W., Kearney, M.F., et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345 (2014), 179–183.
25. Mens, H., Kearney, M., Wiegand, A., Shao, W., Schønning, K., Gerstoft, J., Obel, N., Maldarelli, F., Mellors, J.W., Benfield, T., Coffin, J.M., HIV-1 continues to replicate and evolve in patients with natural control of HIV infection. J. Virol. 84 (2010), 12971–12981.
26. Migueles, S.A., Connors, M., Success and failure of the cellular immune response against HIV-1. Nat. Immunol. 16 (2015), 563–570.
27. O'Connell, K.A., Brennan, T.P., Bailey, J.R., Ray, S.C., Siliciano, R.F., Blankson, J.N., Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus. J. Virol. 84 (2010), 7018–7028.
28. Perreau, M., Savoye, A.L., De Crignis, E., Corpataux, J.M., Cubas, R., Haddad, E.K., De Leval, L., Graziosi, C., Pantaleo, G., Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exp. Med. 210 (2013), 143–156.
29. Purcell, D.F., Martin, M.A., Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67 (1993), 6365–6378.
30. Rasmussen, T.A., Tolstrup, M., Brinkmann, C.R., Olesen, R., Erikstrup, C., Solomon, A., Winckelmann, A., Palmer, S., Dinarello, C., Buzon, M., et al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. Lancet HIV 1 (2014), e13–e21.
31. Rothenberger, M.K., Keele, B.F., Wietgrefe, S.W., Fletcher, C.V., Beilman, G.J., Chipman, J.G., Khoruts, A., Estes, J.D., Anderson, J., Callisto, S.P., et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc. Natl. Acad. Sci. USA 112 (2015), E1126–E1134.
32. Routy, J.P., Tremblay, C.L., Angel, J.B., Trottier, B., Rouleau, D., Baril, J.G., Harris, M., Trottier, S., Singer, J., Chomont, N., et al. Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. HIV Med. 13 (2012), 291–296.
33. ∗57 positive elite suppressors. Retrovirology, 7, 2010, 94.
34. Sandler, N.G., Bosinger, S.E., Estes, J.D., Zhu, R.T., Tharp, G.K., Boritz, E., Levin, D., Wijeyesinghe, S., Makamdop, K.N., del Prete, G.Q., et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511 (2014), 601–605.
35. Simonetti, F.R., Sobolewski, M.D., Fyne, E., Shao, W., Spindler, J., Hattori, J., Anderson, E.M., Watters, S.A., Hill, S., Wu, X., et al. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc. Natl. Acad. Sci. USA 113 (2016), 1883–1888.
36. Søgaard, O.S., Graversen, M.E., Leth, S., Olesen, R., Brinkmann, C.R., Nissen, S.K., Kjaer, A.S., Schleimann, M.H., Denton, P.W., Hey-Cunningham, W.J., et al. The depsipeptide romidepsin reverses HIV-1 latency in vivo. PLoS Pathog., 11, 2015, e1005142.
37. Spivak, A.M., Andrade, A., Eisele, E., Hoh, R., Bacchetti, P., Bumpus, N.N., Emad, F., Buckheit, R. 3rd, McCance-Katz, E.F., Lai, J., et al. A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy. Clin. Infect. Dis. 58 (2014), 883–890.
38. von Stockenstrom, S., Odevall, L., Lee, E., Sinclair, E., Bacchetti, P., Killian, M., Epling, L., Shao, W., Hoh, R., Ho, T., et al. Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA pool during effective HIV therapy. J. Infect. Dis. 212 (2015), 596–607.
39. Wagner, T.A., McLaughlin, S., Garg, K., Cheung, C.Y., Larsen, B.B., Styrchak, S., Huang, H.C., Edlefsen, P.T., Mullins, J.I., Frenkel, L.M., HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 345 (2014), 570–573.
40. Walker, B.D., Yu, X.G., Unravelling the mechanisms of durable control of HIV-1. Nat. Rev. Immunol. 13 (2013), 487–498.
41. Wong, J.K., Hezareh, M., Günthard, H.F., Havlir, D.V., Ignacio, C.C., Spina, C.A., Richman, D.D., Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278 (1997), 1291–1295.